The mitochondrial and autosomal mutation landscapes of prostate cancer.

@article{Lindberg2013TheMA,
  title={The mitochondrial and autosomal mutation landscapes of prostate cancer.},
  author={Johan Lindberg and Ian G Mills and Daniel Klevebring and Wennuan Liu and M{\aa}rten Neiman and Jianfeng Xu and Pernilla Wikstr{\"o}m and Peter N Wiklund and Fredrik Wiklund and Lars Egevad and Henrik Gr{\"o}nberg},
  journal={European urology},
  year={2013},
  volume={63 4},
  pages={702-8}
}
BACKGROUND Prostate cancer (PCa) is the most common cancer in men. PCa is strongly age associated; low death rates in surveillance cohorts call into question the widespread use of surgery, which leads to overtreatment and a reduction in quality of life. There is a great need to increase the understanding of tumor characteristics in the context of disease progression. OBJECTIVE To perform the first multigenome investigation of PCa through analysis of both autosomal and mitochondrial DNA, and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

Histone profiles in cancer.

Pharmacology & therapeutics • 2015
View 6 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 28 references

The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2012
View 1 Excerpt

Advancing a clinically relevant perspective of the clonal nature of cancer.

Proceedings of the National Academy of Sciences of the United States of America • 2011
View 1 Excerpt

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.

Proceedings of the National Academy of Sciences of the United States of America • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…